You are here

Myrbetriq

The Biopharma Patent Cliff: 9 Drugs Losing Exclusivity by the End of 2023

BioSpace

Wed, 08/23/23 - 11:11 am

Eiger Pharmaceuticals

Astellas hit by US patent verdict for incontinence drug

Pharmaphorum

Mon, 06/12/23 - 10:23 am

urinary incontinence

Astellas launches bladder drug, aiming for a $1.9B franchise

Fierce Pharma

Mon, 10/22/12 - 12:11 pm

overactive bladder